| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | tyrosine-ester sulfotransferase activity | 6.68e-09 | 4 | 182 | 4 | GO:0017067 | |
| GeneOntologyMolecularFunction | amine sulfotransferase activity | 6.68e-09 | 4 | 182 | 4 | GO:0047685 | |
| GeneOntologyMolecularFunction | flavonol 3-sulfotransferase activity | 3.32e-08 | 5 | 182 | 4 | GO:0047894 | |
| GeneOntologyMolecularFunction | steroid sulfotransferase activity | 2.29e-07 | 7 | 182 | 4 | GO:0050294 | |
| GeneOntologyMolecularFunction | sulfate binding | 8.12e-07 | 9 | 182 | 4 | GO:0043199 | |
| GeneOntologyMolecularFunction | aryl sulfotransferase activity | 1.34e-06 | 10 | 182 | 4 | GO:0004062 | |
| GeneOntologyMolecularFunction | intramolecular phosphotransferase activity | 2.10e-06 | 11 | 182 | 4 | GO:0016868 | |
| GeneOntologyMolecularFunction | bisphosphoglycerate mutase activity | 2.96e-06 | 4 | 182 | 3 | GO:0004082 | |
| GeneOntologyMolecularFunction | NADPH:quinone reductase activity | 2.96e-06 | 4 | 182 | 3 | GO:0003960 | |
| GeneOntologyMolecularFunction | 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity | 2.96e-06 | 4 | 182 | 3 | GO:0046538 | |
| GeneOntologyMolecularFunction | phosphoglycerate mutase activity | 2.96e-06 | 4 | 182 | 3 | GO:0004619 | |
| GeneOntologyMolecularFunction | 3'-phosphoadenosine 5'-phosphosulfate binding | 4.48e-06 | 13 | 182 | 4 | GO:0050656 | |
| GeneOntologyMolecularFunction | carotenoid dioxygenase activity | 8.26e-05 | 2 | 182 | 2 | GO:0010436 | |
| GeneOntologyMolecularFunction | intramolecular transferase activity | 1.33e-04 | 29 | 182 | 4 | GO:0016866 | |
| GeneOntologyMolecularFunction | beta-carotene 15,15'-dioxygenase activity | 2.46e-04 | 3 | 182 | 2 | GO:0003834 | |
| GeneOntologyMolecularFunction | NADP binding | 2.53e-04 | 62 | 182 | 5 | GO:0050661 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 4.46e-04 | 70 | 182 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol 4-kinase activity | 4.90e-04 | 4 | 182 | 2 | GO:0004430 | |
| GeneOntologyMolecularFunction | lipid kinase activity | 5.20e-04 | 41 | 182 | 4 | GO:0001727 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | DNAH3 ATP7B NSF DDX52 MCM2 ATAD2 DHX15 BPTF ABCA5 DNAH17 DYNC1LI1 DHX32 KIF3C DNAH8 SNRNP200 | 5.22e-04 | 614 | 182 | 15 | GO:0140657 |
| GeneOntologyMolecularFunction | NAD binding | 5.42e-04 | 73 | 182 | 5 | GO:0051287 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 5.49e-04 | 18 | 182 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DNAH3 ATP7B NSF DDX52 MCM2 ATAD2 DHX15 ABCA5 DHX32 KIF3C DNAH8 SNRNP200 | 7.53e-04 | 441 | 182 | 12 | GO:0016887 |
| GeneOntologyMolecularFunction | sulfotransferase activity | 1.58e-03 | 55 | 182 | 4 | GO:0008146 | |
| GeneOntologyMolecularFunction | uridylyltransferase activity | 1.68e-03 | 7 | 182 | 2 | GO:0070569 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.06e-03 | 28 | 182 | 3 | GO:0051959 | |
| GeneOntologyBiologicalProcess | 4-nitrophenol metabolic process | 2.72e-08 | 5 | 179 | 4 | GO:0018960 | |
| GeneOntologyBiologicalProcess | ethanol metabolic process | 3.64e-07 | 18 | 179 | 5 | GO:0006067 | |
| GeneOntologyBiologicalProcess | alcohol metabolic process | CYP7A1 APOB DYSF BCO1 ADH4 SULT1A2 SULT1A4 SULT1A1 SULT1A3 ABCA5 SPHK1 FGFR1 ALDH1A3 G6PD PCK1 SEC14L2 | 6.58e-07 | 412 | 179 | 16 | GO:0006066 |
| GeneOntologyBiologicalProcess | alcohol catabolic process | 3.14e-06 | 47 | 179 | 6 | GO:0046164 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound metabolic process | CYP7A1 APOB DYSF LDHB BCO1 ADH4 SULT1A2 SULT1A4 SULT1A1 SULT1A3 ABCA5 SPHK1 FGFR1 ALDH1A3 RNF180 CTSL G6PD PCK1 SEC14L2 | 3.29e-06 | 641 | 179 | 19 | GO:1901615 |
| GeneOntologyBiologicalProcess | 3'-phosphoadenosine 5'-phosphosulfate metabolic process | 1.20e-05 | 17 | 179 | 4 | GO:0050427 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside bisphosphate metabolic process | 1.20e-05 | 17 | 179 | 4 | GO:0034035 | |
| GeneOntologyBiologicalProcess | ethanol catabolic process | 1.20e-05 | 17 | 179 | 4 | GO:0006068 | |
| GeneOntologyBiologicalProcess | aldehyde metabolic process | 1.92e-05 | 95 | 179 | 7 | GO:0006081 | |
| GeneOntologyBiologicalProcess | primary alcohol metabolic process | 3.90e-05 | 106 | 179 | 7 | GO:0034308 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell development | 4.13e-05 | 73 | 179 | 6 | GO:0060119 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 4.13e-05 | 73 | 179 | 6 | GO:1901616 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 4.27e-05 | 23 | 179 | 4 | GO:0034310 | |
| GeneOntologyBiologicalProcess | organic acid metabolic process | DPYD HACD3 CYP7A1 HMGCL MCCC2 PGAM1 PGAM2 LDHB STAT5A STAT5B ADH4 SULT1A2 SULT1A4 SULT1A1 BCO2 SULT1A3 SPHK1 ASPA PGAM4 FGFR1 ALDH1A3 NOS2 PCK1 | 5.08e-05 | 1064 | 179 | 23 | GO:0006082 |
| GeneOntologyBiologicalProcess | carotene metabolic process | 7.49e-05 | 2 | 179 | 2 | GO:0016119 | |
| GeneOntologyBiologicalProcess | carotene catabolic process | 7.49e-05 | 2 | 179 | 2 | GO:0016121 | |
| GeneOntologyBiologicalProcess | terpene catabolic process | 7.49e-05 | 2 | 179 | 2 | GO:0046247 | |
| GeneOntologyBiologicalProcess | regulation of DNA helicase activity | 7.49e-05 | 2 | 179 | 2 | GO:1905774 | |
| GeneOntologyBiologicalProcess | sulfation | 8.23e-05 | 27 | 179 | 4 | GO:0051923 | |
| GeneOntologyBiologicalProcess | small molecule catabolic process | DPYD CYP7A1 HMGCL MCCC2 PGAM1 PGAM2 ADH4 SULT1A2 SULT1A4 SULT1A1 SULT1A3 NOS2 PCK1 | 8.27e-05 | 421 | 179 | 13 | GO:0044282 |
| GeneOntologyBiologicalProcess | steroid metabolic process | CYP7A1 APOB STAT5A STAT5B SULT1A2 SULT1A4 SULT1A1 SULT1A3 ABCA5 FGFR1 G6PD SEC14L2 | 1.14e-04 | 376 | 179 | 12 | GO:0008202 |
| GeneOntologyBiologicalProcess | skeletal muscle adaptation | 1.63e-04 | 32 | 179 | 4 | GO:0043501 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 1.72e-04 | 13 | 179 | 3 | GO:0009812 | |
| GeneOntologyBiologicalProcess | glyceraldehyde-3-phosphate biosynthetic process | 1.72e-04 | 13 | 179 | 3 | GO:0046166 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell differentiation | 1.91e-04 | 96 | 179 | 6 | GO:0060113 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | STAT5B BCO1 ADH4 SULT1A2 SULT1A4 SULT1A1 BCO2 SULT1A3 ALDH1A3 CTSL | 2.07e-04 | 286 | 179 | 10 | GO:0042445 |
| GeneOntologyBiologicalProcess | terpene metabolic process | 2.23e-04 | 3 | 179 | 2 | GO:0042214 | |
| GeneOntologyBiologicalProcess | tetraterpenoid metabolic process | 2.23e-04 | 3 | 179 | 2 | GO:0016108 | |
| GeneOntologyBiologicalProcess | carotenoid metabolic process | 2.23e-04 | 3 | 179 | 2 | GO:0016116 | |
| GeneOntologyBiologicalProcess | development of secondary male sexual characteristics | 2.23e-04 | 3 | 179 | 2 | GO:0046544 | |
| GeneOntologyBiologicalProcess | small molecule biosynthetic process | DPYD HACD3 CYP7A1 APOB HMGCL PGAM1 PGAM2 LDHB BCO1 SPHK1 PGAM4 ALDH1A3 G6PD PGM2 PCK1 SEC14L2 | 2.80e-04 | 676 | 179 | 16 | GO:0044283 |
| GeneOntologyBiologicalProcess | mechanoreceptor differentiation | 2.95e-04 | 104 | 179 | 6 | GO:0042490 | |
| GeneOntologyBiologicalProcess | carbohydrate biosynthetic process | 3.18e-04 | 247 | 179 | 9 | GO:0016051 | |
| GeneOntologyBiologicalProcess | endosomal vesicle fusion | 3.31e-04 | 16 | 179 | 3 | GO:0034058 | |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | DPYD HACD3 CYP7A1 HMGCL MCCC2 PGAM1 PGAM2 LDHB ADH4 SULT1A2 SULT1A4 SULT1A1 BCO2 SULT1A3 SPHK1 ASPA PGAM4 FGFR1 ALDH1A3 NOS2 PCK1 | 3.52e-04 | 1058 | 179 | 21 | GO:0043436 |
| GeneOntologyBiologicalProcess | inner ear development | 3.79e-04 | 253 | 179 | 9 | GO:0048839 | |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule metabolic process | DPYD TP53I3 HMGCL MCCC2 PGAM1 PGAM2 LDHB SULT1A2 SULT1A4 SULT1A1 SULT1A3 NANS PGAM4 NOS2 G6PD UAP1L1 PGM2 | 3.86e-04 | 767 | 179 | 17 | GO:0055086 |
| GeneOntologyBiologicalProcess | hydrocarbon catabolic process | 4.44e-04 | 4 | 179 | 2 | GO:0120253 | |
| GeneOntologyBiologicalProcess | regulation of DNA duplex unwinding | 4.44e-04 | 4 | 179 | 2 | GO:1905462 | |
| GeneOntologyBiologicalProcess | catechol-containing compound metabolic process | 4.62e-04 | 74 | 179 | 5 | GO:0009712 | |
| GeneOntologyBiologicalProcess | catecholamine metabolic process | 4.62e-04 | 74 | 179 | 5 | GO:0006584 | |
| GeneOntologyBiologicalProcess | cilium movement | 4.75e-04 | 261 | 179 | 9 | GO:0003341 | |
| GeneOntologyBiologicalProcess | membrane fusion | 5.26e-04 | 211 | 179 | 8 | GO:0061025 | |
| GeneOntologyBiologicalProcess | purine-containing compound metabolic process | DPYD TP53I3 HMGCL MCCC2 PGAM1 PGAM2 LDHB SULT1A2 SULT1A4 SULT1A1 SULT1A3 PGAM4 NOS2 G6PD PGM2 | 5.84e-04 | 652 | 179 | 15 | GO:0072521 |
| GeneOntologyBiologicalProcess | regulation of endocytosis | 6.12e-04 | 389 | 179 | 11 | GO:0030100 | |
| GeneOntologyBiologicalProcess | biogenic amine catabolic process | 6.57e-04 | 20 | 179 | 3 | GO:0042402 | |
| GeneOntologyBiologicalProcess | regulation of skeletal muscle adaptation | 6.57e-04 | 20 | 179 | 3 | GO:0014733 | |
| GeneOntologyBiologicalProcess | copper ion transport | 6.57e-04 | 20 | 179 | 3 | GO:0006825 | |
| GeneOntologyBiologicalProcess | biogenic amine metabolic process | 6.62e-04 | 121 | 179 | 6 | GO:0006576 | |
| GeneOntologyBiologicalProcess | retinal metabolic process | 7.62e-04 | 21 | 179 | 3 | GO:0042574 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 5.97e-05 | 25 | 181 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | dynein complex | 1.03e-04 | 54 | 181 | 5 | GO:0030286 | |
| MousePheno | abnormal orientation of cochlear hair cell stereociliary bundles | 1.73e-06 | 35 | 150 | 6 | MP:0004522 | |
| Domain | A2M | 1.64e-06 | 10 | 179 | 4 | PF00207 | |
| Domain | A2M_N_2 | 1.64e-06 | 10 | 179 | 4 | IPR011625 | |
| Domain | A2M_comp | 1.64e-06 | 10 | 179 | 4 | IPR011626 | |
| Domain | A2M_recep | 1.64e-06 | 10 | 179 | 4 | PF07677 | |
| Domain | A2M_comp | 1.64e-06 | 10 | 179 | 4 | PF07678 | |
| Domain | A2M_N | 1.64e-06 | 10 | 179 | 4 | PF01835 | |
| Domain | A2M_N | 1.64e-06 | 10 | 179 | 4 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 1.64e-06 | 10 | 179 | 4 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 1.64e-06 | 10 | 179 | 4 | PS00477 | |
| Domain | A2M_N_2 | 1.64e-06 | 10 | 179 | 4 | PF07703 | |
| Domain | Macroglobln_a2 | 1.64e-06 | 10 | 179 | 4 | IPR001599 | |
| Domain | Phosphogly_mut1 | 3.44e-06 | 4 | 179 | 3 | IPR005952 | |
| Domain | Anaphylatoxin_comp_syst | 8.54e-06 | 5 | 179 | 3 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 8.54e-06 | 5 | 179 | 3 | IPR001840 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 2.25e-05 | 18 | 179 | 4 | IPR008930 | |
| Domain | ANATO | 2.95e-05 | 7 | 179 | 3 | SM00104 | |
| Domain | ANAPHYLATOXIN_2 | 2.95e-05 | 7 | 179 | 3 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 2.95e-05 | 7 | 179 | 3 | PS01177 | |
| Domain | ANATO | 2.95e-05 | 7 | 179 | 3 | PF01821 | |
| Domain | Anaphylatoxin/fibulin | 2.95e-05 | 7 | 179 | 3 | IPR000020 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 4.68e-05 | 8 | 179 | 3 | IPR019565 | |
| Domain | Thiol-ester_cl | 4.68e-05 | 8 | 179 | 3 | PF10569 | |
| Domain | MacrogloblnA2_CS | 4.68e-05 | 8 | 179 | 3 | IPR019742 | |
| Domain | A2M_N_2 | 4.68e-05 | 8 | 179 | 3 | SM01359 | |
| Domain | - | 4.68e-05 | 8 | 179 | 3 | 2.60.40.690 | |
| Domain | A2M_recep | 4.68e-05 | 8 | 179 | 3 | SM01361 | |
| Domain | A2M | 4.68e-05 | 8 | 179 | 3 | SM01360 | |
| Domain | PG/BPGM_mutase_AS | 6.97e-05 | 9 | 179 | 3 | IPR001345 | |
| Domain | N-SET | 9.13e-05 | 2 | 179 | 2 | PF11764 | |
| Domain | N-SET | 9.13e-05 | 2 | 179 | 2 | SM01291 | |
| Domain | COMPASS_Set1_N-SET | 9.13e-05 | 2 | 179 | 2 | IPR024657 | |
| Domain | PGAM | 9.89e-05 | 10 | 179 | 3 | SM00855 | |
| Domain | PG_MUTASE | 9.89e-05 | 10 | 179 | 3 | PS00175 | |
| Domain | His_Pase_superF_clade-1 | 1.79e-04 | 12 | 179 | 3 | IPR013078 | |
| Domain | His_Phos_1 | 1.79e-04 | 12 | 179 | 3 | PF00300 | |
| Domain | - | 1.79e-04 | 12 | 179 | 3 | 1.50.10.20 | |
| Domain | RPE65 | 2.72e-04 | 3 | 179 | 2 | PF03055 | |
| Domain | Carotenoid_Oase | 2.72e-04 | 3 | 179 | 2 | IPR004294 | |
| Domain | Sulfotransfer_1 | 3.78e-04 | 36 | 179 | 4 | PF00685 | |
| Domain | Sulfotransferase_dom | 3.78e-04 | 36 | 179 | 4 | IPR000863 | |
| Domain | PKS_ER | 4.42e-04 | 16 | 179 | 3 | IPR020843 | |
| Domain | ADH_N | 4.42e-04 | 16 | 179 | 3 | PF08240 | |
| Domain | PKS_ER | 4.42e-04 | 16 | 179 | 3 | SM00829 | |
| Domain | ADH_N | 4.42e-04 | 16 | 179 | 3 | IPR013154 | |
| Domain | AAA | 4.82e-04 | 144 | 179 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 4.82e-04 | 144 | 179 | 7 | IPR003593 | |
| Domain | C345C | 5.33e-04 | 17 | 179 | 3 | SM00643 | |
| Domain | - | 5.41e-04 | 4 | 179 | 2 | 3.90.1460.10 | |
| Domain | GTF2I | 5.41e-04 | 4 | 179 | 2 | PS51139 | |
| Domain | GTF2I | 5.41e-04 | 4 | 179 | 2 | PF02946 | |
| Domain | - | 5.41e-04 | 4 | 179 | 2 | 1.20.91.20 | |
| Domain | GTF2I | 5.41e-04 | 4 | 179 | 2 | IPR004212 | |
| Domain | - | 6.35e-04 | 18 | 179 | 3 | 3.90.180.10 | |
| Domain | NTR | 7.49e-04 | 19 | 179 | 3 | PF01759 | |
| Domain | Netrin_module_non-TIMP | 7.49e-04 | 19 | 179 | 3 | IPR018933 | |
| Domain | ADH_zinc_N | 7.49e-04 | 19 | 179 | 3 | PF00107 | |
| Domain | ADH_SF_Zn-type | 7.49e-04 | 19 | 179 | 3 | IPR002085 | |
| Domain | ADH_C | 7.49e-04 | 19 | 179 | 3 | IPR013149 | |
| Domain | - | DNAH3 NSF DDX52 MCM2 TEP1 ATAD2 DHX15 SULT1A2 SAMD9L SULT1A1 ABCA5 NLRC5 DYNC1LI1 DLG3 DHX32 DNAH8 SNRNP200 | 8.53e-04 | 746 | 179 | 17 | 3.40.50.300 |
| Domain | - | 8.75e-04 | 20 | 179 | 3 | 3.40.50.1240 | |
| Domain | His_PPase_superfam | 8.75e-04 | 20 | 179 | 3 | IPR029033 | |
| Domain | NUT | 8.96e-04 | 5 | 179 | 2 | IPR024310 | |
| Domain | NUT_N | 8.96e-04 | 5 | 179 | 2 | IPR024309 | |
| Domain | BRO1 | 8.96e-04 | 5 | 179 | 2 | PF03097 | |
| Domain | NUT | 8.96e-04 | 5 | 179 | 2 | PF12881 | |
| Domain | BRO1_dom | 8.96e-04 | 5 | 179 | 2 | IPR004328 | |
| Domain | BRO1 | 8.96e-04 | 5 | 179 | 2 | SM01041 | |
| Domain | HSP_DnaJ_Cys-rich_dom | 8.96e-04 | 5 | 179 | 2 | IPR001305 | |
| Domain | BRO1 | 8.96e-04 | 5 | 179 | 2 | PS51180 | |
| Domain | - | 8.96e-04 | 5 | 179 | 2 | 1.25.40.280 | |
| Domain | NTR | 1.33e-03 | 23 | 179 | 3 | PS50189 | |
| Domain | Netrin_domain | 1.33e-03 | 23 | 179 | 3 | IPR001134 | |
| Domain | DUF3398 | 1.34e-03 | 6 | 179 | 2 | PF11878 | |
| Domain | DOCK_C/D_N | 1.34e-03 | 6 | 179 | 2 | IPR021816 | |
| Domain | P-loop_NTPase | DNAH3 NSF DDX52 MCM2 TEP1 ATAD2 DHX15 SULT1A2 SAMD9L SULT1A1 ABCA5 NLRC5 DYNC1LI1 DLG3 DHX32 KIF3C DNAH8 SNRNP200 | 1.35e-03 | 848 | 179 | 18 | IPR027417 |
| Domain | GroES-like | 1.51e-03 | 24 | 179 | 3 | IPR011032 | |
| Domain | STAT_TF_DNA-bd_sub | 1.86e-03 | 7 | 179 | 2 | IPR012345 | |
| Domain | STAT | 1.86e-03 | 7 | 179 | 2 | IPR001217 | |
| Domain | STAT_int | 1.86e-03 | 7 | 179 | 2 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 1.86e-03 | 7 | 179 | 2 | IPR013801 | |
| Domain | STAT_bind | 1.86e-03 | 7 | 179 | 2 | PF02864 | |
| Domain | STAT_int | 1.86e-03 | 7 | 179 | 2 | PF02865 | |
| Domain | - | 1.86e-03 | 7 | 179 | 2 | 1.10.532.10 | |
| Domain | STAT_alpha | 1.86e-03 | 7 | 179 | 2 | PF01017 | |
| Domain | Quin_OxRdtase/zeta-crystal_CS | 1.86e-03 | 7 | 179 | 2 | IPR002364 | |
| Domain | QOR_ZETA_CRYSTAL | 1.86e-03 | 7 | 179 | 2 | PS01162 | |
| Domain | - | 1.86e-03 | 7 | 179 | 2 | 1.20.1050.20 | |
| Domain | STAT_TF_prot_interaction | 1.86e-03 | 7 | 179 | 2 | IPR013799 | |
| Domain | STAT_TF_coiled-coil | 1.86e-03 | 7 | 179 | 2 | IPR015988 | |
| Domain | - | 1.86e-03 | 7 | 179 | 2 | 2.60.40.630 | |
| Domain | TIMP-like_OB-fold | 1.91e-03 | 26 | 179 | 3 | IPR008993 | |
| Domain | Ephrin | 2.46e-03 | 8 | 179 | 2 | PF00812 | |
| Domain | STAT_TF_alpha | 2.46e-03 | 8 | 179 | 2 | IPR013800 | |
| Domain | Ephrin_RBD | 2.46e-03 | 8 | 179 | 2 | IPR001799 | |
| Domain | Ephrin | 2.46e-03 | 8 | 179 | 2 | PD002533 | |
| Domain | Ephrin | 2.46e-03 | 8 | 179 | 2 | IPR031328 | |
| Domain | EPHRIN_RBD_1 | 2.46e-03 | 8 | 179 | 2 | PS01299 | |
| Domain | Ephrin_CS | 2.46e-03 | 8 | 179 | 2 | IPR019765 | |
| Domain | EPHRIN_RBD_2 | 2.46e-03 | 8 | 179 | 2 | PS51551 | |
| Domain | DHR-1_domain | 4.75e-03 | 11 | 179 | 2 | IPR027007 | |
| Pathway | WP_RETINOL_METABOLISM | 1.01e-08 | 44 | 140 | 8 | MM15851 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_PHIP_TO_DNA_ADDUCTS | 4.62e-08 | 5 | 140 | 4 | M47807 | |
| Pathway | KEGG_GLYCOLYSIS_GLUCONEOGENESIS | 1.67e-07 | 62 | 140 | 8 | M11521 | |
| Pathway | KEGG_SULFUR_METABOLISM | 6.22e-06 | 13 | 140 | 4 | M18256 | |
| Pathway | WP_SULFATION_BIOTRANSFORMATION_REACTION | 2.01e-05 | 17 | 140 | 4 | M39483 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 3.26e-05 | 7 | 140 | 3 | MM14685 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 5.18e-05 | 8 | 140 | 3 | M27031 | |
| Pathway | WP_ESTROGEN_METABOLISM | 5.93e-05 | 22 | 140 | 4 | MM15888 | |
| Pathway | WP_VITAMIN_A_AND_CAROTENOID_METABOLISM | 6.39e-05 | 43 | 140 | 5 | M39554 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 7.13e-05 | 23 | 140 | 4 | MM14597 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 8.48e-05 | 24 | 140 | 4 | M16289 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOLYSIS | 1.00e-04 | 25 | 140 | 4 | M47623 | |
| Pathway | REACTOME_GLUCONEOGENESIS | 1.18e-04 | 26 | 140 | 4 | MM15392 | |
| Pathway | WP_GLYCOLYSIS_AND_GLUCONEOGENESIS | 1.46e-04 | 51 | 140 | 5 | MM15928 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 1.49e-04 | 11 | 140 | 3 | MM1430 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 1.98e-04 | 12 | 140 | 3 | MM1368 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 2.55e-04 | 13 | 140 | 3 | M4732 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 4.00e-04 | 15 | 140 | 3 | M7146 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE | 4.00e-04 | 15 | 140 | 3 | MM14643 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE | 4.88e-04 | 16 | 140 | 3 | M639 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AUTOPHAGOSOME_AND_LYSOSOME_FUSION_TETHERING_FACTOR | 4.88e-04 | 16 | 140 | 3 | M47978 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 5.85e-04 | 39 | 140 | 4 | MM15695 | |
| Pathway | WP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY | 5.89e-04 | 17 | 140 | 3 | MM15944 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 5.89e-04 | 17 | 140 | 3 | MM1369 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | FAT4 PDCD6IP MAN1C1 TOM1L1 APOB DYSF PGAM1 PGAM2 GDI2 LDHB BROX CRYZ HMCN1 NANS PGAM4 C4A C4B TAGLN2 C5 VPS28 ALDH1A3 CTSL G6PD PGM2 CDH11 SEC14L2 | 8.25e-11 | 1070 | 182 | 26 | 23533145 |
| Pubmed | 7.26e-10 | 4 | 182 | 4 | 24318996 | ||
| Pubmed | 7.26e-10 | 4 | 182 | 4 | 33414449 | ||
| Pubmed | 7.26e-10 | 4 | 182 | 4 | 8943792 | ||
| Pubmed | A single mutation converts the nucleotide specificity of phenol sulfotransferase from PAP to AMP. | 7.26e-10 | 4 | 182 | 4 | 12390022 | |
| Pubmed | 7.26e-10 | 4 | 182 | 4 | 8424956 | ||
| Pubmed | 7.26e-10 | 4 | 182 | 4 | 8288252 | ||
| Pubmed | 7.26e-10 | 4 | 182 | 4 | 25370010 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | PDCD6IP DNAJA2 TMEM59 VPS50 AOX1 ADGRV1 NEB DYSF ATAD2 GDI2 LDHB BROX PARP4 CRYZ AP2M1 EFNB1 PKHD1 MLLT3 TAGLN2 C5 VPS28 G6PD FKBP4 PCK1 | 8.23e-10 | 1016 | 182 | 24 | 19056867 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | PDCD6IP HACD3 NSF NUDT21 DDX52 DNAJA2 MCM2 APOB HMGCL MCCC2 CMYA5 ATAD2 PGAM1 GDI2 LDHB KHSRP FANCD2 DHX15 RBM25 AP2M1 DYNC1LI1 RRP7A KIF3C EIF3B TAGLN2 G6PD SNRNP200 FKBP4 | 1.75e-09 | 1425 | 182 | 28 | 30948266 |
| Pubmed | 3.61e-09 | 5 | 182 | 4 | 11389699 | ||
| Pubmed | 3.61e-09 | 5 | 182 | 4 | 29908303 | ||
| Pubmed | 3.61e-09 | 5 | 182 | 4 | 25053625 | ||
| Pubmed | 3.61e-09 | 5 | 182 | 4 | 24802129 | ||
| Pubmed | 2.51e-08 | 7 | 182 | 4 | 12438748 | ||
| Pubmed | 2.51e-08 | 7 | 182 | 4 | 9370299 | ||
| Pubmed | Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain. | 5.00e-08 | 8 | 182 | 4 | 10594240 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | STARD13 PDCD6IP HACD3 DNAJA2 MCCC2 PGAM1 GDI2 EPG5 DHX15 ARID1B AP2M1 NANS EIF3B TAGLN2 EML1 G6PD SNRNP200 PGM2 FKBP4 | 5.65e-08 | 807 | 182 | 19 | 30575818 |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | NSF DNAJC16 DNAJA2 TUT7 MRPL28 GDI2 LDHB MRPS22 ITPR2 PARP4 AP2M1 KIAA1217 C4A TAGLN2 C5 G6PD PGM2 FKBP4 | 6.76e-08 | 732 | 182 | 18 | 34732716 |
| Pubmed | 8.96e-08 | 9 | 182 | 4 | 8887328 | ||
| Pubmed | Ethanol sulfation by the human cytosolic sulfotransferases: a systematic analysis. | 8.96e-08 | 9 | 182 | 4 | 23207770 | |
| Pubmed | 8.96e-08 | 9 | 182 | 4 | 19548878 | ||
| Pubmed | 8.96e-08 | 9 | 182 | 4 | 9177785 | ||
| Pubmed | 8.96e-08 | 9 | 182 | 4 | 9166597 | ||
| Pubmed | 8.96e-08 | 9 | 182 | 4 | 8468045 | ||
| Pubmed | Chromosomal localization of the mouse genes encoding the ERK1 and ERK2 isoforms of MAP kinases. | 8.96e-08 | 9 | 182 | 4 | 9060415 | |
| Pubmed | PDCD6IP HACD3 NSF DOCK8 NUDT21 ITSN1 DNAJA2 SORBS1 PGAM1 GDI2 LDHB MRPS22 KHSRP ITPR2 DHX15 CDKL5 DZANK1 AP2M1 GRK2 KIAA1217 PGAM4 DLG3 C4A C4B SNRNP200 | 1.36e-07 | 1431 | 182 | 25 | 37142655 | |
| Pubmed | Phosphoglycerate Mutase Cooperates with Chk1 Kinase to Regulate Glycolysis. | 1.41e-07 | 3 | 182 | 3 | 32634742 | |
| Pubmed | Physical and functional interactions between STAP-2/BKS and STAT5. | 1.41e-07 | 3 | 182 | 3 | 15611091 | |
| Pubmed | 1.41e-07 | 3 | 182 | 3 | 33914812 | ||
| Pubmed | Identification of two human brain aryl sulfotransferase cDNAs. | 1.41e-07 | 3 | 182 | 3 | 8363592 | |
| Pubmed | Mouse phosphoglycerate mutase M and B isozymes: cDNA cloning, enzyme activity assay and mapping. | 1.41e-07 | 3 | 182 | 3 | 11250083 | |
| Pubmed | 1.41e-07 | 3 | 182 | 3 | 9855620 | ||
| Pubmed | 1.41e-07 | 3 | 182 | 3 | 8912648 | ||
| Pubmed | Developmental activation of phosphoglycerate mutase-2 in the testis of the mouse. | 1.41e-07 | 3 | 182 | 3 | 2824255 | |
| Pubmed | Mouse complement component C4 is devoid of classical pathway C5 convertase subunit activity. | 1.41e-07 | 3 | 182 | 3 | 8649451 | |
| Pubmed | 1.49e-07 | 10 | 182 | 4 | 7601475 | ||
| Pubmed | 1.65e-07 | 114 | 182 | 8 | 28245920 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | ATP7B NSF YIPF4 DNAJA2 TOM1L1 PI4K2A APOB PTDSS2 STEAP2 FANCD2 BROX CRYZ AP2M1 EFNB1 SULT1A3 VPS41 DYNC1LI1 FGFR1 C5 DOCK6 CDH17 | 2.00e-07 | 1061 | 182 | 21 | 33845483 |
| Pubmed | Localization of the murine cholecystokinin A and B receptor genes. | 2.33e-07 | 11 | 182 | 4 | 7613026 | |
| Pubmed | 2.33e-07 | 11 | 182 | 4 | 11154739 | ||
| Pubmed | Tbx6, a mouse T-Box gene implicated in paraxial mesoderm formation at gastrulation. | 2.33e-07 | 11 | 182 | 4 | 8954725 | |
| Pubmed | Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes. | 2.33e-07 | 11 | 182 | 4 | 9034160 | |
| Pubmed | 2.33e-07 | 11 | 182 | 4 | 10720750 | ||
| Pubmed | SETD1A AKT3 SETD1B TUT7 DGKE PGAM1 KCNH3 KHSRP SULT1A2 ARID1B SULT1A4 SULT1A1 SULT1A3 MTM1 DNAH17 PGAM4 UAP1L1 | 3.41e-07 | 730 | 182 | 17 | 34857952 | |
| Pubmed | Identification of four chromosomal loci determining obesity in a multifactorial mouse model. | 3.48e-07 | 12 | 182 | 4 | 7706460 | |
| Pubmed | Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. | 5.00e-07 | 180 | 182 | 9 | 30110629 | |
| Pubmed | 5.00e-07 | 13 | 182 | 4 | 10585447 | ||
| Pubmed | Structural and chemical profiling of the human cytosolic sulfotransferases. | 5.00e-07 | 13 | 182 | 4 | 17425406 | |
| Pubmed | DNAJA2 MCM2 CMYA5 NEB GDI2 LDHB KHSRP DHX15 HMCN1 DHX32 C4A C4B EIF3B TAGLN2 ALDH1A3 G6PD SNRNP200 FKBP4 | 5.43e-07 | 844 | 182 | 18 | 25963833 | |
| Pubmed | Impaired mast cell-dependent natural immunity in complement C3-deficient mice. | 5.62e-07 | 4 | 182 | 3 | 9367154 | |
| Pubmed | 5.62e-07 | 4 | 182 | 3 | 25195573 | ||
| Pubmed | Phylogeny of the C3/C4/C5 complement-component gene family indicates that C5 diverged first. | 5.62e-07 | 4 | 182 | 3 | 8015436 | |
| Pubmed | 5.62e-07 | 4 | 182 | 3 | 32152050 | ||
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | PDCD6IP HACD3 NSF NUDT21 DNAJA2 MCM2 MCCC2 LDHB ELAC2 RBM25 CRYZ NANS EIF3B SNRNP200 FKBP4 | 8.28e-07 | 607 | 182 | 15 | 39147351 |
| Pubmed | 9.47e-07 | 15 | 182 | 4 | 1741163 | ||
| Pubmed | PDCD6IP NUDT21 MCM2 GDI2 LDHB STAT5B KHSRP DHX15 BROX AP2M1 EIF3B TAGLN2 VPS28 G6PD SNRNP200 FKBP4 | 1.11e-06 | 707 | 182 | 16 | 19738201 | |
| Pubmed | PDCD6IP ITSN1 DNAJA2 TOM1L1 STAT5B AP2M1 EFNB2 EIF3B TAGLN2 VPS28 | 1.32e-06 | 261 | 182 | 10 | 33277362 | |
| Pubmed | NSF DNAJA2 MCM2 MCCC2 PGAM1 MRPS22 KHSRP FANCD2 BPTF ARID1B PCDH15 DYNC1LI1 | 1.35e-06 | 396 | 182 | 12 | 26687479 | |
| Pubmed | 1.40e-06 | 5 | 182 | 3 | 15192652 | ||
| Pubmed | 1.40e-06 | 5 | 182 | 3 | 17200182 | ||
| Pubmed | Predominant role for C5b-9 in renal ischemia/reperfusion injury. | 1.40e-06 | 5 | 182 | 3 | 10811844 | |
| Pubmed | Intranasal peptide-induced tolerance and linked suppression: consequences of complement deficiency. | 1.40e-06 | 5 | 182 | 3 | 25039245 | |
| Pubmed | Formation of high affinity C5 convertase of the classical pathway of complement. | 1.40e-06 | 5 | 182 | 3 | 12878586 | |
| Pubmed | NSF NUDT21 DNAJA2 PGAM1 GDI2 LDHB KHSRP AP2M1 PGAM4 DYNC1LI1 C4A C4B G6PD FKBP4 | 1.44e-06 | 552 | 182 | 14 | 36293380 | |
| Pubmed | 2.10e-06 | 18 | 182 | 4 | 20056724 | ||
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | PDCD6IP DNAJA2 MCM2 PGAM1 LDHB GRK2 MTM1 PGAM4 EIF3B G6PD SNRNP200 | 2.25e-06 | 344 | 182 | 11 | 30333137 |
| Pubmed | SETD1A PDCD6IP NSF DNAJA2 MCM2 LDHB KHSRP DHX15 BPTF PARP4 EIF3B SNRNP200 FKBP4 | 2.31e-06 | 494 | 182 | 13 | 26831064 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | STARD13 SETD1A SETD1B PDCD6IP HACD3 DDX52 DNAJA2 TUT7 MCM2 MCCC2 ATAD2 LDHB ELAC2 KHSRP DHX15 EIF2D AP2M1 NANS DYNC1LI1 EIF3B G6PD SNRNP200 | 2.65e-06 | 1353 | 182 | 22 | 29467282 |
| Pubmed | 2.79e-06 | 6 | 182 | 3 | 16849499 | ||
| Pubmed | TOM1L1 VPS50 PI4K2A DGKE CMYA5 ATAD2 ADAM28 DZANK1 CRYZ SAMD9L MTM1 TMEM184C C5 TARBP1 IQUB | 3.70e-06 | 686 | 182 | 15 | 29987050 | |
| Pubmed | 4.05e-06 | 21 | 182 | 4 | 32301970 | ||
| Pubmed | Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. | 4.86e-06 | 7 | 182 | 3 | 14660741 | |
| Pubmed | Adipocyte STAT5 deficiency promotes adiposity and impairs lipid mobilisation in mice. | 4.86e-06 | 7 | 182 | 3 | 27858140 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | FAT4 ITGA11 HACD3 DNAJC16 YIPF4 TUT7 TMEM59 KIAA0319L PTDSS2 ELAC2 MRPS22 KHSRP ITPR2 DHX15 CSGALNACT2 LNPEP C4A TAGLN2 CTSL G6PD | 5.50e-06 | 1201 | 182 | 20 | 35696571 |
| Pubmed | 5.54e-06 | 241 | 182 | 9 | 23125841 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | SETD1A PDCD6IP HACD3 NSF NUDT21 DDX52 MCM2 MCCC2 LDHB MRPS22 STAT5A KHSRP DHX15 RBM25 AP2M1 HPF1 RRP7A EIF3B TAGLN2 SNRNP200 LRIF1 | 6.21e-06 | 1318 | 182 | 21 | 30463901 |
| Pubmed | 6.51e-06 | 132 | 182 | 7 | 22496890 | ||
| Pubmed | PI4K2B AKT3 PDCD6IP HACD3 NSF NUDT21 DNAJA2 TMEM59 MCM2 MRPL28 DGKE MRPS22 KHSRP ITPR2 FANCD2 DHX15 AP2M1 DYNC1LI1 DHX32 EIF3B G6PD SNRNP200 | 7.13e-06 | 1440 | 182 | 22 | 30833792 | |
| Pubmed | STARD13 DDX52 ITSN1 APOB HMGCL NEB PGAM1 PGAM2 KHSRP SCML4 BPTF GTF2IRD2B AP2M1 PGAM4 GTF2IRD2 PKHD1 TMEM184C DLG3 FGFR1 DNAH8 PCK1 FBXO15 | 7.29e-06 | 1442 | 182 | 22 | 35575683 | |
| Pubmed | 7.45e-06 | 250 | 182 | 9 | 18660489 | ||
| Pubmed | 7.74e-06 | 8 | 182 | 3 | 24474777 | ||
| Pubmed | 7.74e-06 | 8 | 182 | 3 | 24567357 | ||
| Pubmed | The role of complement in cryoglobulin-induced immune complex glomerulonephritis. | 7.74e-06 | 8 | 182 | 3 | 16272350 | |
| Pubmed | 7.74e-06 | 8 | 182 | 3 | 28301559 | ||
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | SETD1A PDCD6IP HACD3 NUDT21 DNAJA2 MCM2 PGAM1 KHSRP DHX15 EIF2D ARID1B WDCP DYNC1LI1 DHX32 TAGLN2 VPS28 CTSL | 7.87e-06 | 922 | 182 | 17 | 27609421 |
| Pubmed | 8.72e-06 | 193 | 182 | 8 | 19343046 | ||
| Pubmed | 1.02e-05 | 329 | 182 | 10 | 35562734 | ||
| Pubmed | Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma. | 1.02e-05 | 329 | 182 | 10 | 34316702 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | PDCD6IP NSF NUDT21 DNAJA2 MCM2 PGAM1 GDI2 LDHB MRPS22 KHSRP DHX15 AP2M1 SULT1A1 DYNC1LI1 EIF3B TAGLN2 G6PD SNRNP200 FKBP4 | 1.06e-05 | 1149 | 182 | 19 | 35446349 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | DNAH3 HACD3 MCM2 PGAM1 PGAM2 LDHB ELAC2 MRPS22 KHSRP RBM25 AP2M1 KIAA1217 DYNC1LI1 EIF3B SNRNP200 FKBP4 | 1.09e-05 | 847 | 182 | 16 | 35235311 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | ITSN1 DNAJA2 TUT7 KIAA0319L SORBS1 MCCC2 PGAM1 GDI2 EIF2D GRK2 MTUS1 NANS WDCP KIAA1217 DYNC1LI1 FKBP4 | 1.19e-05 | 853 | 182 | 16 | 28718761 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | SETD1B ITSN1 DNAJA2 VPS50 SORBS1 MCCC2 PGAM2 LDHB ZZZ3 WDCP KIAA1217 ARID5B LRIF1 | 1.49e-05 | 588 | 182 | 13 | 38580884 |
| Pubmed | 1.63e-05 | 152 | 182 | 7 | 34299191 | ||
| Pubmed | 1.65e-05 | 10 | 182 | 3 | 30429287 | ||
| Pubmed | Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects. | 1.65e-05 | 10 | 182 | 3 | 11535246 | |
| Pubmed | 1.78e-05 | 103 | 182 | 6 | 10574462 | ||
| Pubmed | Evolutionarily conserved regulators of tau identify targets for new therapies. | ATP7B HACD3 TMEM59 KIAA0319L PI4K2A PGAM1 PGAM2 GDI2 BROX EFNB1 FGFR1 TAGLN2 | 1.96e-05 | 516 | 182 | 12 | 36610398 |
| Pubmed | PDCD6IP HACD3 NSF PI4K2A MCM2 GDI2 KHSRP MAP1LC3C NANS MTM1 FKBP4 | 2.13e-05 | 437 | 182 | 11 | 20562859 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 2.25e-05 | 220 | 182 | 8 | 35785414 | |
| Interaction | SULT1C2 interactions | 5.65e-07 | 19 | 180 | 5 | int:SULT1C2 | |
| Interaction | BIRC3 interactions | PDCD6IP HACD3 NSF NUDT21 DDX52 DNAJA2 MCM2 APOB HMGCL MCCC2 CMYA5 ATAD2 PGAM1 GDI2 LDHB KHSRP FANCD2 DHX15 RBM25 AP2M1 SPHK1 DYNC1LI1 RRP7A KIF3C EIF3B TAGLN2 G6PD SNRNP200 FKBP4 | 7.41e-06 | 1334 | 180 | 29 | int:BIRC3 |
| Cytoband | 16p12.1 | 1.32e-04 | 25 | 182 | 3 | 16p12.1 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.78e-07 | 9 | 113 | 4 | 1234 | |
| GeneFamily | Bisphosphoglycerate phosphatases | 9.47e-07 | 4 | 113 | 3 | 1082 | |
| GeneFamily | Sulfotransferases, cytosolic | 1.38e-06 | 14 | 113 | 4 | 762 | |
| GeneFamily | Dyneins, axonemal | 1.52e-04 | 17 | 113 | 3 | 536 | |
| GeneFamily | Ferlin family | 5.71e-04 | 6 | 113 | 2 | 828 | |
| GeneFamily | Ephrins | 1.06e-03 | 8 | 113 | 2 | 546 | |
| GeneFamily | Complement system|Sushi domain containing | 1.46e-03 | 36 | 113 | 3 | 492 | |
| Coexpression | ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP | CDR2 MAN1C1 TOM1L1 ADGRV1 ITPR2 PARP4 GTF2IRD2B EIF2D EFNB2 NANS WDCP MTM1 HPF1 GTF2IRD2 KATNIP TAGLN2 VPS28 TARBP1 SEC14L2 | 8.37e-06 | 863 | 180 | 19 | M4950 |
| Coexpression | LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_UP | 9.97e-06 | 108 | 180 | 7 | MM1334 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_DN | PI4K2B NIPSNAP3B TOM1L1 KIAA0319L STAP2 HMGCL MCCC2 STAT5A PAOX MTUS1 DLG3 DHX32 ALDH1A3 | 1.09e-05 | 436 | 180 | 13 | MM1326 |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | ATP7B PDCD6IP NUDT21 DNAJA2 TMEM59 TP53I3 MCCC2 GDI2 LDHB STAT5A STAT5B KHSRP ITPR2 DHX15 SULT1A2 EIF2D AP2M1 SULT1A1 VPS41 DYNC1LI1 MLLT3 C4A EIF3B TAGLN2 FKBP4 | 1.14e-05 | 1399 | 180 | 25 | M535 |
| Coexpression | MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP | STEAP2 MRPS22 HHIP SULT1A2 EFNB1 HMCN1 KIAA1217 MLLT3 FGFR1 CDH11 | 1.59e-05 | 265 | 180 | 10 | M2255 |
| Coexpression | VERNOCHET_ADIPOGENESIS | 2.05e-05 | 24 | 180 | 4 | MM1317 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_LATE_MESOTHELIAL_CELL | DPYD TOM1L1 AOX1 STAP2 PTDSS2 CMYA5 ITPR2 HHIP EFNB2 BCO2 MTUS1 PTPRQ C4A C4B PCK1 FYB2 | 3.06e-05 | 704 | 180 | 16 | M45672 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.34e-05 | 91 | 182 | 7 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_1000 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FAT4 COL19A1 CYP7A1 APOB ADGRV1 NEB HMCN1 PTPRQ PCDH15 PKHD1 ANO3 | 2.89e-10 | 184 | 182 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FAT4 COL19A1 CYP7A1 APOB ADGRV1 NEB HMCN1 PTPRQ PCDH15 PKHD1 ANO3 | 2.89e-10 | 184 | 182 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FAT4 COL19A1 CYP7A1 APOB ADGRV1 NEB HMCN1 PTPRQ PCDH15 PKHD1 ANO3 | 2.89e-10 | 184 | 182 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal-Intermediate|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.38e-07 | 199 | 182 | 9 | cf592d93612023a13de21e0fb8c6b13714f9af71 | |
| ToppCell | droplet-Spleen-nan-21m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.92e-07 | 169 | 182 | 8 | 7962165cab84af73d20b56eb70b1ed87c94025ef | |
| ToppCell | COPD-Epithelial-Mesothelial|Epithelial / Disease state, Lineage and Cell class | 1.10e-06 | 188 | 182 | 8 | 159d63ecc3653a7449fc6acefd6ef0464845260e | |
| ToppCell | COPD-Epithelial-Mesothelial|COPD / Disease state, Lineage and Cell class | 1.15e-06 | 189 | 182 | 8 | 79bb2593ad5d17f94b17972884241f03a0f43770 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.15e-06 | 189 | 182 | 8 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-06 | 133 | 182 | 7 | f303ab771482281d8793974f9f5279cee09431fe | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-06 | 194 | 182 | 8 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-06 | 194 | 182 | 8 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 1.56e-06 | 197 | 182 | 8 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Mesofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-06 | 197 | 182 | 8 | 88a86286b9c3ea3b076d7464faec42d0392ee7f8 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Mesofibroblastic-Mesothelia|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-06 | 197 | 182 | 8 | 2773d2eb5f232a7e49da116efffcb6bf5eb90810 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.56e-06 | 197 | 182 | 8 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.68e-06 | 199 | 182 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.16e-06 | 92 | 182 | 6 | ed282f0f3da1593bdec5a2b20af5b8f058574167 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)--|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.16e-06 | 92 | 182 | 6 | c5f30d58f235f7a72dfe63f58999c4680502576f | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.16e-06 | 92 | 182 | 6 | 27072dbf6819dca41e41267dc250abfaaf175b2f | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.38e-06 | 146 | 182 | 7 | 86cddd0e7f954547b7ffdccb0329cd5c4b725ac1 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 4.37e-06 | 160 | 182 | 7 | 8aaf6ac4f33ea291387fdbf9ff1a91d559391774 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-06 | 169 | 182 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.51e-06 | 170 | 182 | 7 | 37c647f67505aa1ff12a198df1eeddd9f406fe15 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.51e-06 | 170 | 182 | 7 | b180ec9a1b79025a180c8559c27c31272410dea8 | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.77e-06 | 171 | 182 | 7 | 4e856441063e9825b6f87a1d3dd19c77dae4662c | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.87e-06 | 175 | 182 | 7 | 21bc0e59a9509d38751ce6aad2325f341bc70eff | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.17e-06 | 176 | 182 | 7 | c2c4306476989bc2fb30dab00250ef7915842f13 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tnaive/CM_CD4|GI_large-bowel / Manually curated celltypes from each tissue | 8.48e-06 | 177 | 182 | 7 | eb87ea93e36a8f97442ec8515f658ee61932dc0f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.80e-06 | 178 | 182 | 7 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-1|TCGA-Liver / Sample_Type by Project: Shred V9 | 8.80e-06 | 178 | 182 | 7 | 51c59dabf2d7aef1b1964f6f766d5ec07ef90f5a | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_8|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.12e-06 | 179 | 182 | 7 | 163f5430d72ea0c1b239ea5d21e53be536636d3d | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_8|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.12e-06 | 179 | 182 | 7 | 0624dd537a68736f4d7b8b4de2c56168ed0e60a9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.81e-06 | 181 | 182 | 7 | 30729f0364f719c044712a51453e22dc2c1a232b | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 1.02e-05 | 182 | 182 | 7 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | IPF-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 1.05e-05 | 183 | 182 | 7 | 7df20e3172a1220ff427f30181f4f0c3b7fe2d42 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.13e-05 | 185 | 182 | 7 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | COPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 1.13e-05 | 185 | 182 | 7 | 23579988036fc1925992c31919750f9b3fe9f790 | |
| ToppCell | Control-Epithelial-Mesothelial|Epithelial / Disease state, Lineage and Cell class | 1.13e-05 | 185 | 182 | 7 | 0af540323c0113203ba6c1a4cb32d2fb9cf79d39 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_1-Mesothelial|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.17e-05 | 186 | 182 | 7 | 7812ed80d2378aca9957ef22fc3c8fb7fb58434b | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.17e-05 | 186 | 182 | 7 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.25e-05 | 188 | 182 | 7 | 117dc80fa940e6aa1b0187a43fdde33f3fcb578f | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 1.30e-05 | 189 | 182 | 7 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 1.30e-05 | 189 | 182 | 7 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | 343B-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-05 | 189 | 182 | 7 | c26428871dc3261327d89cacaba6e21e004ff1f3 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 189 | 182 | 7 | 27e5d706f10a6221f314faf642eede15deab3165 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-05 | 190 | 182 | 7 | 106ea0bb7b99c697ffc5443d72343df2484250c7 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.39e-05 | 191 | 182 | 7 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.39e-05 | 191 | 182 | 7 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.39e-05 | 191 | 182 | 7 | 2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-Treg-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.44e-05 | 192 | 182 | 7 | d85a785a12076e34c404171363a647f318926b18 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-Treg|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.44e-05 | 192 | 182 | 7 | 230f3090607a62bb6d1e1f4b0341ee96d93f1c00 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.49e-05 | 193 | 182 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.49e-05 | 193 | 182 | 7 | ad3f4fcc8e2816d696cbcde744dc16500e51ccac | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.49e-05 | 193 | 182 | 7 | f582e939e3e08a8a3f71deec78c33715be8faa51 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.49e-05 | 193 | 182 | 7 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.49e-05 | 193 | 182 | 7 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-05 | 193 | 182 | 7 | 456aa8a8f1f9cbba0bd618a5f623909079c0f56b | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.54e-05 | 194 | 182 | 7 | 68004855b23fe1e31e8452d70effabc78a4a0bd3 | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 1.54e-05 | 194 | 182 | 7 | 777ce41c3f22c591e2d81120f189b834e53ffb4b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-05 | 194 | 182 | 7 | 69bff17df4a760ccf081cf52ff04af02c14f448d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.54e-05 | 194 | 182 | 7 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 1.54e-05 | 194 | 182 | 7 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | IPF-Epithelial-Mesothelial|Epithelial / Disease state, Lineage and Cell class | 1.54e-05 | 194 | 182 | 7 | d8a26da856a85e3d001d406e992cb18fdd58baef | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-05 | 194 | 182 | 7 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | COVID-19-kidney-Glomerular_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.54e-05 | 194 | 182 | 7 | 660535b492445063d965095a50e1e299ce04c50a | |
| ToppCell | Children_(3_yrs)-Endothelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.59e-05 | 195 | 182 | 7 | 094cf6591daa5ffad36e44122b6f524a3a34c2fd | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 1.59e-05 | 195 | 182 | 7 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.64e-05 | 196 | 182 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | COVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.64e-05 | 196 | 182 | 7 | ac28e9be288af6f00a841aea4ce4b99aed6b4505 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.70e-05 | 197 | 182 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.70e-05 | 197 | 182 | 7 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | BL|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.70e-05 | 197 | 182 | 7 | 1acf0191fa0a25cd20bfd9ea7bf727a1555986a1 | |
| ToppCell | PBMC-Mild-cDC_0|Mild / Compartment, Disease Groups and Clusters | 1.75e-05 | 198 | 182 | 7 | fb873b7636bb1c7b119dd5b23d7a20f518e6c6da | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Mesothelial_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.75e-05 | 198 | 182 | 7 | 86736f01e61bf4961f060b24ee1f1f48340737dd | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.75e-05 | 198 | 182 | 7 | 09be07ebfc3e49c3858e9b74605b69cf4fc28b56 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-05 | 198 | 182 | 7 | 92416e65a0dc1a4bf931833407620ea05d362f56 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Mesothelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.81e-05 | 199 | 182 | 7 | ca970114b5aef4518ce580897a62ac88688b2671 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.81e-05 | 199 | 182 | 7 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 1.81e-05 | 199 | 182 | 7 | e222b90caf45904d8f763574e7b6aac13333df92 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.81e-05 | 199 | 182 | 7 | dc88ce36cc066eb6c28cfd5b9b60fe07f8cc7b53 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.87e-05 | 200 | 182 | 7 | 25f4c051c2e869481f33c22ad54de97efac444ad | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial-Proteoglycan-expressing_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.87e-05 | 200 | 182 | 7 | da45a85a4667965b24ba824af871157af5b4cd19 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.87e-05 | 200 | 182 | 7 | a6f0f5f644b7262878b0b9d4d90ee407c4124dd9 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial-Proteoglycan-expressing_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.87e-05 | 200 | 182 | 7 | aafe594c88710f8c53d59667cdac5035e08f5511 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.43e-05 | 149 | 182 | 6 | c5eedb54ef2e0f131aa6730612c921bc19479632 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.43e-05 | 149 | 182 | 6 | a22417286de8606f0cc94f86b70bce17aeefb9c2 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-OPC_related-Oligodendrocyte/OPC|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 3.70e-05 | 151 | 182 | 6 | 4533bccc996395f74b16af939ce79b6fe253c073 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-OPC_related|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 3.70e-05 | 151 | 182 | 6 | edb2f59789c295838d2030b80c792cbea25eaa3d | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.60e-05 | 157 | 182 | 6 | 432b8719a8afd289cf48068e12c26a349d753fcc | |
| ToppCell | facs-Marrow-T-cells-24m-Hematologic-MPP_Fraction_B|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.11e-05 | 160 | 182 | 6 | b3f7ef7e682b48a83ca425f5c439336e96168300 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.47e-05 | 162 | 182 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tfh|GI_large-bowel / Manually curated celltypes from each tissue | 5.66e-05 | 163 | 182 | 6 | 4104d3b9748b39cb0744c9be76db21bdda566a0d | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.86e-05 | 164 | 182 | 6 | 583dda853cee9491dbdcb228c23d8deadc20eb08 | |
| ToppCell | Control-Epithelial-Mesothelial|Control / Disease state, Lineage and Cell class | 6.26e-05 | 166 | 182 | 6 | 1ed3788257e14f097862b999f020bfe2a57de52b | |
| ToppCell | Control-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 6.26e-05 | 166 | 182 | 6 | 32ebaefa6c074b28193fff764ee7c2c0e9357e20 | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 6.48e-05 | 167 | 182 | 6 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.15e-05 | 170 | 182 | 6 | d99f61aa85ea3f775165cb433421e6f1cda4f96b | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.15e-05 | 170 | 182 | 6 | dbd6c9c7be824a1ff1b31af791064127cafbd194 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.15e-05 | 170 | 182 | 6 | 928e42c51a7079c506f21c669c4e4c1a0df84d77 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.15e-05 | 170 | 182 | 6 | 615cf9639c66b3fbd984ebe3f345280005d3c38a | |
| Drug | cyclobenzaprine | 1.13e-09 | 15 | 182 | 6 | CID000002895 | |
| Drug | naphthalenemethanol | 5.83e-08 | 14 | 182 | 5 | CID000020908 | |
| Drug | dopamine-4-O-sulfate | 1.36e-07 | 7 | 182 | 4 | CID000123932 | |
| Drug | 2-naphthylsulfate | 1.36e-07 | 7 | 182 | 4 | CID000074428 | |
| Drug | 2-iodo-4-azidophenol | 1.36e-07 | 7 | 182 | 4 | CID003035977 | |
| Drug | luciferyl sulfate | 1.36e-07 | 7 | 182 | 4 | CID011953812 | |
| Drug | dopamine 3-O-sulfate | 2.70e-07 | 8 | 182 | 4 | CID000122136 | |
| Drug | 6-anilino-2-thiouracil | 2.70e-07 | 8 | 182 | 4 | CID003037707 | |
| Drug | 2-iodophenol | 2.70e-07 | 8 | 182 | 4 | CID000010784 | |
| Drug | N-hydroxy-2-acetylaminofluorene | 2.23e-06 | 48 | 182 | 6 | CID000005896 | |
| Drug | EM-139 | 2.67e-06 | 13 | 182 | 4 | CID000131427 | |
| Drug | deoxoestrone | 3.71e-06 | 14 | 182 | 4 | CID000005888 | |
| Drug | 3-phosphoglycerate | 3.82e-06 | 114 | 182 | 8 | CID000000724 | |
| Drug | Pimozide [2062-78-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 4.21e-06 | 196 | 182 | 10 | 3178_DN | |
| Drug | arylsulfate | 5.03e-06 | 15 | 182 | 4 | CID000074426 | |
| Drug | allulose 6-phosphate | 6.47e-06 | 162 | 182 | 9 | CID000000603 | |
| Drug | A-44 | 6.67e-06 | 16 | 182 | 4 | CID000120353 | |
| Drug | acetate | DNAH3 APOB MCCC2 LDHB STAT5A STAT5B ADH4 SULT1A2 SULT1A1 DNAH17 ASPA DYNC1LI1 ALDH1A3 NOS2 G6PD PGM2 PCK1 | 6.83e-06 | 599 | 182 | 17 | CID000000175 |
| Drug | aldonates | 7.94e-06 | 90 | 182 | 7 | CID000000752 | |
| Drug | benzilic acid | 8.67e-06 | 17 | 182 | 4 | CID000006463 | |
| Drug | 2-phosphoglycerate | 1.06e-05 | 94 | 182 | 7 | CID000000059 | |
| Drug | mefenamic acid | 1.09e-05 | 37 | 182 | 5 | CID000004044 | |
| Drug | sulfate | SELL NUDT21 AOX1 TP53I3 PELI2 APOB ATAD2 PGAM2 LDHB HHIP SULT1A2 AP2M1 SULT1A4 EFNB1 SULT1A1 SULT1A3 PGAM4 ARHGEF9 DLG3 C4A FGFR1 ALDH1A3 NOS2 G6PD FKBP4 PCK1 | 1.33e-05 | 1292 | 182 | 26 | CID000001117 |
| Drug | epicatechin-3-gallate | 1.34e-05 | 65 | 182 | 6 | CID000065056 | |
| Drug | AC1Q6OHG | 1.39e-05 | 19 | 182 | 4 | CID000115063 | |
| Drug | pedunculagin | 1.39e-05 | 19 | 182 | 4 | CID000442688 | |
| Drug | glycolic acid | 1.47e-05 | 66 | 182 | 6 | CID000000757 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 1.51e-05 | 180 | 182 | 9 | 4344_UP | |
| Drug | Phosphoadenosine Phosphosulfate | 1.72e-05 | 7 | 182 | 3 | ctd:D010724 | |
| Drug | PLP-Glu | 1.73e-05 | 20 | 182 | 4 | CID000444293 | |
| Drug | N-hydroxy-2-aminofluorene | 2.13e-05 | 21 | 182 | 4 | CID000005895 | |
| Drug | MeA alpha C | 2.58e-05 | 22 | 182 | 4 | CID000062244 | |
| Drug | AABSSN | 2.58e-05 | 22 | 182 | 4 | CID005464134 | |
| Drug | N-hydroxy-4-aminobiphenyl | 2.73e-05 | 8 | 182 | 3 | ctd:C014593 | |
| Drug | Guaifenesin [93-14-1]; Down 200; 20.2uM; MCF7; HT_HG-U133A | 2.74e-05 | 194 | 182 | 9 | 3431_DN | |
| Drug | NDPS | 2.91e-05 | 45 | 182 | 5 | CID000090363 | |
| Drug | 1IIg | 2.91e-05 | 45 | 182 | 5 | CID000001682 | |
| Drug | fructose-1,6-diphosphate sodium salt | 3.00e-05 | 151 | 182 | 8 | CID000000718 | |
| Drug | taselin | 3.11e-05 | 23 | 182 | 4 | CID000023846 | |
| Drug | flavin adenine dinucleotide sodium | DPYD ATP7B AOX1 APOB MCCC2 FANCD2 PAOX CRYZ C4A C5 NOS2 G6PD | 3.13e-05 | 356 | 182 | 12 | CID000000703 |
| Drug | novobiocin sodium, USP; Down 200; 100uM; MCF7; HG-U133A | 3.21e-05 | 198 | 182 | 9 | 342_DN | |
| Drug | AalphaC | 3.70e-05 | 24 | 182 | 4 | CID000062805 | |
| Drug | glycerol | PDCD6IP NUDT21 DDX52 AOX1 MCCC2 ADGRV1 PGAM2 LDHB BCO1 ADH4 PTPN5 BPTF ARHGEF9 DLG3 VPS28 ALDH1A3 NOS2 G6PD PCK1 | 3.86e-05 | 829 | 182 | 19 | CID000000753 |
| Drug | sulfamethazine | 4.00e-05 | 48 | 182 | 5 | CID000005327 | |
| Drug | salicylamide | 4.00e-05 | 48 | 182 | 5 | CID000005147 | |
| Drug | 2,5-dihydroxybenzoic acid | 4.07e-05 | 9 | 182 | 3 | ctd:C010925 | |
| Drug | 3-hydroxy-3-methyloxindole | 4.07e-05 | 9 | 182 | 3 | CID000151066 | |
| Drug | AzMC | 4.38e-05 | 25 | 182 | 4 | CID000064986 | |
| Drug | minoxidil sulphate | 4.38e-05 | 25 | 182 | 4 | CID000004202 | |
| Drug | 2-pentanone | 4.38e-05 | 25 | 182 | 4 | CID000007895 | |
| Drug | alpha-methyldopamine | 5.15e-05 | 26 | 182 | 4 | CID000017005 | |
| Drug | glycolithocholic acid | 5.15e-05 | 26 | 182 | 4 | CID000115245 | |
| Drug | 1m2q | 5.15e-05 | 26 | 182 | 4 | CID005326637 | |
| Drug | 2,4-dihydroxy-N-(4-hydroxyphenyl)benzamide | 5.79e-05 | 10 | 182 | 3 | ctd:C585912 | |
| Drug | Atenolol | 5.92e-05 | 52 | 182 | 5 | ctd:D001262 | |
| Drug | Hydroxytryptophol | 6.36e-05 | 2 | 182 | 2 | ctd:D006917 | |
| Drug | ethyl-3-(4'-geranyloxy-3'-methoxyphenyl)-2-propenoate | 6.36e-05 | 2 | 182 | 2 | ctd:C403134 | |
| Drug | 5-hydroxymethylfurfural | 6.36e-05 | 2 | 182 | 2 | ctd:C008046 | |
| Drug | Bay a 4798 | 6.36e-05 | 2 | 182 | 2 | CID000182522 | |
| Drug | 6-hydroxymelatonin | 6.36e-05 | 2 | 182 | 2 | ctd:C012365 | |
| Drug | androstenediol | 7.11e-05 | 54 | 182 | 5 | CID000010634 | |
| Drug | Glu-P-2 | 8.02e-05 | 29 | 182 | 4 | CID000049970 | |
| Drug | primaquine | 8.06e-05 | 89 | 182 | 6 | CID000004908 | |
| Drug | 3,3'-T2 | 9.20e-05 | 30 | 182 | 4 | CID000065559 | |
| Drug | A2'p5'A2'p5'A | 1.05e-04 | 31 | 182 | 4 | CID000122642 | |
| Drug | barium hydroxide | 1.05e-04 | 31 | 182 | 4 | CID000028387 | |
| Drug | acetaminophen sulfate | 1.05e-04 | 31 | 182 | 4 | CID000083939 | |
| Drug | DCNP | 1.35e-04 | 33 | 182 | 4 | CID000012066 | |
| Drug | 3-methyloxindole | 1.35e-04 | 13 | 182 | 3 | CID000150923 | |
| Drug | 2,2'-azobis(2,4-dimethylvaleronitrile | 1.35e-04 | 13 | 182 | 3 | CID000091537 | |
| Drug | glyceraldehyde | 1.37e-04 | 140 | 182 | 7 | CID000000751 | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.40e-04 | 188 | 182 | 8 | 6451_DN | |
| Drug | dE-Oxy | 1.45e-04 | 99 | 182 | 6 | CID003081580 | |
| Drug | 4-nonylphenol | 1.61e-04 | 64 | 182 | 5 | CID000001752 | |
| Drug | ropivacaine | 1.71e-04 | 14 | 182 | 3 | ctd:C037663 | |
| Drug | corilagin | 1.73e-04 | 65 | 182 | 5 | CID000073568 | |
| Drug | Tadjakonine [11087-94-8]; Up 200; 7.4uM; PC3; HT_HG-U133A | 1.74e-04 | 194 | 182 | 8 | 4599_UP | |
| Drug | 15(S)-15-methyl Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A | 1.74e-04 | 194 | 182 | 8 | 7494_UP | |
| Drug | Homochlorcyclizine dihydrochloride [1982-36-1]; Up 200; 10.4uM; HL60; HT_HG-U133A | 1.80e-04 | 195 | 182 | 8 | 2386_UP | |
| Drug | Naphazoline hydrochloride [550-99-2]; Up 200; 16.2uM; HL60; HG-U133A | 1.80e-04 | 195 | 182 | 8 | 1966_UP | |
| Drug | Quinacrine dihydrochloride dihydrate [6151-30-0]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 1.80e-04 | 195 | 182 | 8 | 3179_DN | |
| Drug | glucose-6-P | 1.84e-04 | 366 | 182 | 11 | CID000000208 | |
| Drug | Folinic acid calcium salt [6035-45-6]; Down 200; 7.8uM; PC3; HT_HG-U133A | 1.86e-04 | 196 | 182 | 8 | 3703_DN | |
| Drug | 8-azaadenine | 1.90e-04 | 3 | 182 | 2 | ctd:C006654 | |
| Drug | 2-aminothiophenol | 1.90e-04 | 3 | 182 | 2 | ctd:C005464 | |
| Drug | 3,3'-diiodothyronine | 1.90e-04 | 3 | 182 | 2 | ctd:C030629 | |
| Drug | 5-hydroxy-3-methylindole | 1.90e-04 | 3 | 182 | 2 | CID000192734 | |
| Drug | 5-hydroxyindole | 1.90e-04 | 3 | 182 | 2 | ctd:C026785 | |
| Drug | Minoxidil | 1.90e-04 | 3 | 182 | 2 | ctd:D008914 | |
| Drug | Isoproterenol | SELL AOX1 SORBS1 MCCC2 NEB ATAD2 LDHB STAT5A PTPN5 GRK2 SULT1A1 SPHK1 ARID5B C4B CTSL NOS2 G6PD FKBP4 CDH11 PCK1 | 1.91e-04 | 1016 | 182 | 20 | ctd:D007545 |
| Drug | Azaperone [1649-18-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.93e-04 | 197 | 182 | 8 | 3573_DN | |
| Drug | Viomycin sulfate [37883-00-4]; Down 200; 5.2uM; HL60; HT_HG-U133A | 1.93e-04 | 197 | 182 | 8 | 2979_DN | |
| Drug | Dubinidine [22964-77-8]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 1.93e-04 | 197 | 182 | 8 | 3554_UP | |
| Drug | Hydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; PC3; HT_HG-U133A | 1.93e-04 | 197 | 182 | 8 | 7309_DN | |
| Drug | Butoconazole nitrate [32872-77-1]; Up 200; 8.4uM; HL60; HT_HG-U133A | 1.93e-04 | 197 | 182 | 8 | 2427_UP | |
| Drug | Sulfasalazine [599-79-1]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.00e-04 | 198 | 182 | 8 | 5446_UP | |
| Drug | Cisapride [81098-60-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 2.00e-04 | 198 | 182 | 8 | 3305_DN | |
| Drug | Flecainide acetate [54143-56-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 2.00e-04 | 198 | 182 | 8 | 3418_DN | |
| Drug | Ketotifen fumarate [34580-14-8]; Up 200; 9.4uM; PC3; HT_HG-U133A | 2.07e-04 | 199 | 182 | 8 | 5842_UP | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Up 200; 15.6uM; MCF7; HT_HG-U133A | 2.07e-04 | 199 | 182 | 8 | 4749_UP | |
| Disease | Malignant neoplasm of breast | DPYD ATP7B COL19A1 TP53I3 DGKE SORBS1 DYSF LDHB MRPS22 STAT5A EPG5 ARID1B SULT1A1 WDCP NLRC5 DHX32 FGFR1 NOS2 PURG | 2.10e-05 | 1074 | 174 | 19 | C0006142 |
| Disease | neurodevelopmental disorder with speech impairment and dysmorphic facies (implicated_via_orthology) | 3.46e-05 | 2 | 174 | 2 | DOID:0070417 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | DPYD DNAH3 CPAMD8 ATP7B APOB CDKL5 HHIP ZZZ3 ABCA5 PKHD1 DLG3 DNAH8 SNRNP200 IQUB | 7.75e-05 | 702 | 174 | 14 | C0009402 |
| Disease | Chromosome Aberrations | 1.07e-04 | 16 | 174 | 3 | C0008625 | |
| Disease | Autosome Abnormalities | 1.07e-04 | 16 | 174 | 3 | C0004403 | |
| Disease | Antibody Deficiency Syndrome | 1.29e-04 | 17 | 174 | 3 | C0003257 | |
| Disease | cortical surface area measurement | CPAMD8 AKT3 ITGA11 CNNM2 NSF YIPF4 TUT7 ADGRV1 DYSF PRPF18 ELAC2 HHIP ARID1B EFNB2 CSGALNACT2 PKHD1 MLLT3 FGFR1 EML1 CDH11 | 1.40e-04 | 1345 | 174 | 20 | EFO_0010736 |
| Disease | Lung Neoplasms | 1.87e-04 | 265 | 174 | 8 | C0024121 | |
| Disease | Malignant neoplasm of lung | 1.92e-04 | 266 | 174 | 8 | C0242379 | |
| Disease | Liver carcinoma | DPYD MCM2 ADH4 FANCD2 HHIP ARID1B CD5L BCO2 MTUS1 TAGLN2 PCK1 | 2.25e-04 | 507 | 174 | 11 | C2239176 |
| Disease | Immunologic Deficiency Syndromes | 3.27e-04 | 23 | 174 | 3 | C0021051 | |
| Disease | Noninfiltrating Intraductal Carcinoma | 3.42e-04 | 5 | 174 | 2 | C0007124 | |
| Disease | Atypical Ductal Breast Hyperplasia | 3.42e-04 | 5 | 174 | 2 | C1332347 | |
| Disease | obsolete_red blood cell distribution width | SETD1B DOCK8 YIPF4 ITSN1 TUT7 MCM2 MRPL28 APOB EPG5 GTF2IRD2B SPHK1 WDCP KIAA1217 GTF2IRD2 DHX32 FGFR1 NUTM2F DOCK6 G6PD | 3.99e-04 | 1347 | 174 | 19 | EFO_0005192 |
| Disease | serum metabolite measurement | DPYD DNAJC16 CCDC81 APOB BCO1 ADH4 PAOX PARP4 SULT1A2 DNAH17 ARID5B VPS41 PCDH15 MLLT3 DOCK6 | 5.06e-04 | 945 | 174 | 15 | EFO_0005653 |
| Disease | obesity | 5.94e-04 | 241 | 174 | 7 | EFO_0001073 | |
| Disease | Mental Retardation, X-Linked | 6.58e-04 | 29 | 174 | 3 | C1136249 | |
| Disease | liver disease (biomarker_via_orthology) | 7.12e-04 | 7 | 174 | 2 | DOID:409 (biomarker_via_orthology) | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 7.12e-04 | 7 | 174 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | Developmental Disabilities | 7.28e-04 | 30 | 174 | 3 | C0008073 | |
| Disease | Attached earlobe | 9.46e-04 | 8 | 174 | 2 | HP_0009907 | |
| Disease | Complement deficiency disease | 9.65e-04 | 33 | 174 | 3 | C0272242 | |
| Disease | waist-hip ratio | DPYD CPAMD8 ITGA11 PDCD6IP MYOZ2 STAT5B BPTF HHIP DNAH17 ARID5B FGFR1 DOCK6 ANO3 FKBP4 PCK1 IQUB PURG | 9.79e-04 | 1226 | 174 | 17 | EFO_0004343 |
| Disease | interleukin 18 measurement | 1.08e-03 | 76 | 174 | 4 | EFO_0004581 | |
| Disease | Nonsyndromic Deafness | 1.36e-03 | 81 | 174 | 4 | C3711374 | |
| Disease | feeling nervous measurement | 1.78e-03 | 87 | 174 | 4 | EFO_0009597 | |
| Disease | Combined immunodeficiency | 1.82e-03 | 41 | 174 | 3 | C0494261 | |
| Disease | Colonic Neoplasms | 2.12e-03 | 152 | 174 | 5 | C0009375 | |
| Disease | level of Ceramide (d42:2) in blood serum | 2.19e-03 | 12 | 174 | 2 | OBA_2045186 | |
| Disease | X-12707 measurement | 2.19e-03 | 12 | 174 | 2 | EFO_0800720 | |
| Disease | Malignant Head and Neck Neoplasm | 2.23e-03 | 44 | 174 | 3 | C0278996 | |
| Disease | Neurodevelopmental Disorders | 2.27e-03 | 93 | 174 | 4 | C1535926 | |
| Disease | Malignant tumor of colon | 2.58e-03 | 159 | 174 | 5 | C0007102 | |
| Disease | Mental Retardation, X-Linked Nonsyndromic | 2.58e-03 | 13 | 174 | 2 | C3501611 | |
| Disease | brain connectivity measurement | 2.68e-03 | 400 | 174 | 8 | EFO_0005210 | |
| Disease | cannabis dependence measurement | 2.87e-03 | 48 | 174 | 3 | EFO_0008457 | |
| Disease | ascorbic acid 3-sulfate measurement | 3.00e-03 | 14 | 174 | 2 | EFO_0800173 | |
| Disease | abdominal aortic aneurysm (biomarker_via_orthology) | 3.00e-03 | 14 | 174 | 2 | DOID:7693 (biomarker_via_orthology) | |
| Disease | apolipoprotein B to apolipoprotein A1 ratio | 3.04e-03 | 49 | 174 | 3 | EFO_0021897 | |
| Disease | thyroid stimulating hormone measurement | 3.16e-03 | 323 | 174 | 7 | EFO_0004748 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 3.41e-03 | 51 | 174 | 3 | cv:CN043650 | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 3.45e-03 | 15 | 174 | 2 | DOID:13413 (biomarker_via_orthology) | |
| Disease | amenorrhea, response to antineoplastic agent | 3.45e-03 | 15 | 174 | 2 | EFO_0010269, GO_0097327 | |
| Disease | nose morphology measurement | 3.50e-03 | 329 | 174 | 7 | EFO_0007843 | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 3.52e-03 | 171 | 174 | 5 | DOID:9352 (is_implicated_in) | |
| Disease | Synostotic Posterior Plagiocephaly | 3.93e-03 | 16 | 174 | 2 | C1833340 | |
| Disease | Malaria, susceptibility to | 3.93e-03 | 16 | 174 | 2 | cv:C1970028 | |
| Disease | Craniosynostosis, Type 1 | 3.93e-03 | 16 | 174 | 2 | C4551902 | |
| Disease | Acrocephaly | 3.93e-03 | 16 | 174 | 2 | C0030044 | |
| Disease | – | 3.93e-03 | 16 | 174 | 2 | 611162 | |
| Disease | Trigonocephaly | 3.93e-03 | 16 | 174 | 2 | C0265535 | |
| Disease | Scaphycephaly | 3.93e-03 | 16 | 174 | 2 | C0265534 | |
| Disease | Synostotic Anterior Plagiocephaly | 3.93e-03 | 16 | 174 | 2 | C2931150 | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 3.93e-03 | 16 | 174 | 2 | DOID:0070296 (is_implicated_in) | |
| Disease | Metopic synostosis | 3.93e-03 | 16 | 174 | 2 | C1860819 | |
| Disease | Ciliopathies | 4.15e-03 | 110 | 174 | 4 | C4277690 | |
| Disease | attempted suicide | 4.17e-03 | 178 | 174 | 5 | EFO_0004321 | |
| Disease | phospholipids in medium HDL measurement | 4.22e-03 | 55 | 174 | 3 | EFO_0022295 | |
| Disease | Brachycephaly | 4.44e-03 | 17 | 174 | 2 | C0221356 | |
| Disease | non-alcoholic steatohepatitis (biomarker_via_orthology) | 4.44e-03 | 17 | 174 | 2 | DOID:0080547 (biomarker_via_orthology) | |
| Disease | otitis media (biomarker_via_orthology) | 4.44e-03 | 17 | 174 | 2 | DOID:10754 (biomarker_via_orthology) | |
| Disease | Breast Carcinoma | 4.81e-03 | 538 | 174 | 9 | C0678222 | |
| Disease | coronary artery disease | DPYD FAT4 CNNM2 DSCAM DOCK8 APOB EPG5 SCML4 LNPEP KIAA1217 PKHD1 C5 EML1 DOCK6 CDH17 | 4.88e-03 | 1194 | 174 | 15 | EFO_0001645 |
| Disease | total lipids in medium HDL measurement | 4.90e-03 | 58 | 174 | 3 | EFO_0022310 | |
| Disease | free cholesterol in medium HDL measurement | 4.90e-03 | 58 | 174 | 3 | EFO_0022267 | |
| Disease | Disorder of organic acid metabolism | 4.97e-03 | 18 | 174 | 2 | cv:C1263739 | |
| Disease | cholesterol in medium HDL measurement | 5.14e-03 | 59 | 174 | 3 | EFO_0021903 | |
| Disease | neuroticism measurement, wellbeing measurement, depressive symptom measurement | 5.53e-03 | 19 | 174 | 2 | EFO_0007006, EFO_0007660, EFO_0007869 | |
| Disease | free cholesterol in HDL measurement | 5.65e-03 | 61 | 174 | 3 | EFO_0022264 | |
| Disease | phospholipids in HDL measurement | 5.65e-03 | 61 | 174 | 3 | EFO_0022293 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FYKVLKEELSPIQPV | 231 | Q9NVA4 | |
| FKNAVVPIKLVPDLY | 886 | Q8WWZ7 | |
| CPVPEYIKGFQKLLS | 536 | Q9Y2R4 | |
| RVKKLYPQLPAEIAG | 211 | Q9HCE0 | |
| AYQVTLPGQEPIVKK | 471 | P41214 | |
| IPEKQPFKDLGNLRY | 281 | P55884 | |
| RGPVVLKEPEKQQLY | 181 | Q9NQ75 | |
| YVLPNFEVKITPGKP | 236 | P0C0L5 | |
| ELPGVKKYEVVYPIR | 21 | Q9UKQ2 | |
| GVTNVKPGDKVIPLY | 81 | P08319 | |
| GKAEIKYDPEVIQPL | 526 | P35670 | |
| FILPIEVYFKNKEEP | 81 | P42568 | |
| QPKYITILKEGEPIG | 1631 | Q6V0I7 | |
| ELKPEKVPQVEVYFF | 5451 | Q8WXG9 | |
| EIFGPVQPILKFKSI | 411 | P47895 | |
| LPSFGPYLEQRKKII | 876 | Q12882 | |
| PAVGKKPLDLFRLYV | 1161 | Q8NFD5 | |
| GILYEPPAEKEQKVL | 76 | O43866 | |
| LLYPEVFEKFKIQPP | 446 | Q6PL18 | |
| VIDPGFAKQKVYNPR | 436 | O43143 | |
| DLGELVVVPLYPKEK | 301 | Q7L7V1 | |
| GFSYKVIRVPPEKVD | 246 | Q9BYV7 | |
| DYPYGPVENKIKVLQ | 351 | Q12830 | |
| QDVYDKKLVPPFKPQ | 411 | Q9Y243 | |
| DGFLLTPVQKICKYP | 236 | O43307 | |
| LGKKQVPPDLFQPYI | 136 | P25098 | |
| GIKSFIAYLIPDVPK | 926 | Q9BYT9 | |
| ELLEFKFKYPQAPVI | 251 | Q06278 | |
| LIEKIPTAKPELFAY | 741 | P49756 | |
| KLTPIGYIPKEDALN | 551 | P35558 | |
| FDKPGGPENLYVKEV | 6 | Q53FA7 | |
| KPVIGSQYPLEKVAE | 296 | Q08257 | |
| QIELEKPKPIPYIYG | 471 | P11413 | |
| FVDPKEYDIPGLVRK | 311 | P54829 | |
| YLKEVVNQPFPFGDK | 841 | Q14571 | |
| PDEFPVYVGINEAKK | 136 | Q9NWY4 | |
| FGEKPNLPEYKVAAI | 196 | Q9ULD8 | |
| GVEPLPQEVLKKYII | 711 | P49736 | |
| KPKYGRFDVVPLVLQ | 296 | P35228 | |
| NKIPFKPDGVYIEEV | 126 | Q5TC84 | |
| ITPLEDLYKRFKIPG | 46 | P50395 | |
| FQNIYPKPVTEIAKP | 246 | Q5T3J3 | |
| KEPIIKKFEEEGNPY | 506 | Q9HCC0 | |
| FLDLVKPEPVYKLTQ | 61 | Q9P035 | |
| HKPLPIIDFGKIIIY | 111 | A6NFK2 | |
| AVIKYEEKPPKPAFQ | 821 | Q9ULD2 | |
| KLTPGLYEFKVIVEG | 371 | Q8IZA0 | |
| FKIPVLPYGQRLVID | 966 | O60303 | |
| KERYIPKQLNPIFGE | 1286 | A9Z1Z3 | |
| GFPYKIPAVVVEKDA | 306 | Q9Y6G9 | |
| YLIIENFIPPEEKNK | 631 | O14782 | |
| YPQIGDKLDIICPKV | 51 | P52799 | |
| DLAKPLVKFIQQTYP | 16 | Q8WUM4 | |
| CQYKDTLPKEVFPVL | 231 | Q8WUM4 | |
| PQVKEQVKLYEGIPV | 281 | Q6ZWH5 | |
| EEAIPARKLKNFYPG | 961 | Q96JB1 | |
| KLEKPPKEGVYELAV | 136 | Q9BS92 | |
| NEVVPDSFKKPYLIK | 151 | Q9Y2G8 | |
| VKYPNPEEGKGVLTL | 291 | Q96G03 | |
| IKEGDYNPLFIPVAV | 326 | P14151 | |
| QYPLKKLDLVAIPDF | 411 | Q9UIQ6 | |
| EPKVVNGPEILNKYV | 281 | P46459 | |
| PTGIPIVYELDKNLK | 211 | Q8N0Y7 | |
| EVPFAPSGLKVRYLK | 391 | Q96CW1 | |
| GKVIPLRESYLKEFP | 401 | Q9UKX5 | |
| VPIEAKYIFPLDDKA | 651 | Q9UKK3 | |
| GKVIFYAKDIAPPLI | 471 | Q86WI3 | |
| FVKAIGFVYVKEPPV | 4336 | Q96RW7 | |
| PEKPNGIIIAYEVLY | 731 | Q9UMZ3 | |
| PELLEQKPYGKAVDV | 181 | Q6P2M8 | |
| RIIAVFKPKNEEPYG | 146 | Q9BTU6 | |
| RKIIGVFKPKSEEPY | 141 | Q8TCG2 | |
| VDGFEKPKLLLEQYP | 16 | Q9NRN9 | |
| YRLIIPPIKEGKEGF | 1181 | Q96QU1 | |
| GRQIVVKYPPGKVIE | 291 | O60884 | |
| LKLAIPEGKQVFLYP | 131 | P04114 | |
| PEGKQVFLYPEKDEP | 136 | P04114 | |
| LPEVKFPEVDVLTKY | 3786 | P04114 | |
| RLNAEPGKKVFYPVV | 381 | Q8N6G5 | |
| YPSPDIFLVIKLEKV | 331 | Q96HP0 | |
| EFVYKEPAITKLPEI | 1811 | Q8NF50 | |
| GGLFEVPVPDYKQLK | 1256 | Q9UFH2 | |
| VLPKPDYEVFLKVLN | 1661 | Q8TD57 | |
| LKQNKVYTPGEIPIV | 91 | Q6ZN84 | |
| VEKLVPDSLYVPFKE | 271 | Q01850 | |
| RDTIKIFPKGLPEEY | 86 | Q14993 | |
| YPGVPVEELFKLLKE | 701 | P11362 | |
| VKAALADILKPVNPY | 166 | Q8NCQ5 | |
| GIPYPIKVQVKDSLD | 366 | P01031 | |
| KEELIPLQFYGTLPK | 236 | Q8N3K9 | |
| VQKYVLPKFELLIDP | 221 | Q8IZJ3 | |
| YKTPIFLNEVLVKLP | 1516 | Q15811 | |
| VIYPKIGDKLDIICP | 51 | P98172 | |
| ALDKNKIPYKGFIPE | 646 | Q9BSK4 | |
| KIPYKGFIPEDLEAF | 651 | Q9BSK4 | |
| GINGFIPRKDIKPEY | 686 | P55287 | |
| VEILKEGLQKYTYPP | 406 | Q6TDU7 | |
| LYPIAIFIKPKSIEA | 736 | Q92796 | |
| VLRKIEKPFGLYPNF | 356 | Q9NR34 | |
| LFNPEVAKYLKVPQD | 576 | Q8NA54 | |
| NVFKFIIPQIVKYSP | 116 | P07195 | |
| LGILPPLNDIEFKYK | 486 | P22680 | |
| YQKLRKTEIPEQFGP | 491 | O00423 | |
| AVPKNYKLVAAPLFE | 186 | O43809 | |
| KGQEKYIPQVAVLPL | 296 | P52429 | |
| GKEKFQIPPNAELKY | 231 | Q02790 | |
| PFGKGIYIDPEILEK | 656 | Q92674 | |
| FKYIKPITLPDGKIQ | 66 | Q9NVP4 | |
| EAIGVDFPVKVPYRK | 346 | Q86UP8 | |
| EAIGVDFPVKVPYRK | 346 | Q6EKJ0 | |
| FKAENPEPLVFGVKY | 531 | Q12864 | |
| GVPPEKVKSYIYQLI | 106 | O76039 | |
| VVKAPKLFPVAYNLI | 191 | O76054 | |
| VIGEFKGLFKIYPLP | 1541 | O75923 | |
| PTGIPIVYELDKNLK | 211 | P18669 | |
| YVLPNFEVKITPGKP | 236 | P0C0L4 | |
| QPAIIKTLFEKLPEY | 146 | Q9BXW9 | |
| AKFPNKIPVVVERYP | 31 | Q9BXW4 | |
| NKYGIFLKVSEVRPP | 281 | Q9UJV8 | |
| KASEPKYQLFVPQLV | 201 | Q86T96 | |
| PVPSVGEYLKKEIGQ | 151 | Q6QHF9 | |
| PEVVKQPVYLPSKDG | 321 | A1L443 | |
| PEVVKQPVYLPSKDG | 321 | Q5VZR2 | |
| PPLKLNGIIRKYTVF | 1211 | O60469 | |
| KPLRIIGDPYKVQQA | 281 | Q92945 | |
| YFPKEGRKILTPIIF | 196 | P82650 | |
| PKVEFAPDIGLQYKG | 531 | Q8TDW5 | |
| KVPDYKDKAVFGVPL | 651 | Q9Y3M8 | |
| VKREGPKYVIDVEQP | 206 | Q9UGK3 | |
| EVYLDLVKKGVQFPP | 141 | O75674 | |
| DQGIVIPLQYPVEKK | 91 | O60880 | |
| INALYPEGQAPVKKI | 66 | P37802 | |
| AESPKPIFAKIINLY | 726 | Q8IVG5 | |
| EIPGIKIFQINAPIY | 531 | P58743 | |
| PTGIPIVYELNKELK | 211 | P15259 | |
| APNKEPVKYGELVVL | 11 | Q9HAT8 | |
| IEELQKPGKNFPYPE | 361 | Q5VWT5 | |
| VLKGIQKFPGINYPV | 91 | P35914 | |
| RQFLKYVDPKLGVPL | 151 | Q9BVG9 | |
| TIVNVYGVVKFFKPP | 21 | Q9NUX5 | |
| FKKEPGTLVYIEKPR | 511 | Q5T5P2 | |
| GYPPEDIFNLVGKKV | 321 | Q9NR45 | |
| KIDEFYVGPVPPKQV | 91 | Q9UPS6 | |
| VDGYVKPQIKQVVPE | 696 | P51692 | |
| DFYKIPIEIVNKTLP | 246 | Q8NFT2 | |
| YFPSLQPRKDLGKVV | 3326 | P08F94 | |
| LPVPKFKLDEFYIGQ | 76 | O15047 | |
| VKILTPEGEIFKEPY | 251 | Q96QV1 | |
| KGVPLIKYFAEALGP | 16 | P0DMN0 | |
| KGVPLIKYFAEALGP | 16 | P0DMM9 | |
| VDGYVKPQIKQVVPE | 691 | P42229 | |
| YFQKIPTEAPQLELK | 331 | Q5VW32 | |
| YVIFKIPATVPEGKK | 196 | Q9HAY6 | |
| RKGKVFQEPLFYEAP | 101 | P07711 | |
| EGKEFPPCAIEVYKI | 211 | P45381 | |
| KTPIERIPYLGFKQI | 336 | Q14865 | |
| KPVDYFVLILQGKVE | 681 | Q9H8M5 | |
| KPVPGFQVAYVVFQK | 111 | Q9Y3A4 | |
| FPLLPQEEKAYIRGK | 186 | Q8N9Z0 | |
| YAISIPEKEQPLKGE | 341 | Q6DJT9 | |
| SFDIVKYELEKLPPV | 66 | Q96JG6 | |
| KIVIFQSKPEIQYAP | 176 | Q9BXS4 | |
| PPQLEKYLEAIKIFS | 141 | Q9BQ52 | |
| KEYGIFVLQPKDPGV | 2421 | Q99973 | |
| DKEVIYICPFNGPIK | 46 | Q13496 | |
| KGVPLIKYFAEALGP | 16 | P50225 | |
| KGVPLIKYFAEALGP | 16 | P50226 | |
| KPEPPKYGIVQEFFR | 1281 | O94964 | |
| AQPKKLTPVQVLEYG | 856 | Q9BX66 | |
| IGAPGNKPELYEEVK | 11 | Q9UK41 | |
| VPYVDEEGNLVKPLK | 361 | Q3KQV9 | |
| KDPVPLFKIYVAELI | 221 | Q13084 | |
| FKEIGQLKAISPYLP | 436 | P49754 | |
| FLVEPEDVYIVKNKP | 46 | Q6ZN44 | |
| LLPVEKLPKYAQAGF | 461 | O75643 | |
| YVPVVAFRLEPKDGK | 321 | Q9NYA1 | |
| GEEFKTKKPLLIYPI | 216 | Q9BSR8 | |
| VIKPVLPKLNNLFEY | 346 | Q13395 | |
| AKIVIPKGFDFYVPA | 1101 | Q502W6 | |
| QKPYYLGPVVEKRAV | 606 | Q9H6R7 | |
| PPVIPVLQEIYKGEK | 1186 | Q5VYS8 | |
| GYKIQPKEEDQKPLT | 46 | Q99633 | |
| QKKADIGLPYPQRVV | 546 | Q8IYH5 | |
| AGPYLERKKVQQLPE | 106 | Q8N228 | |
| GFEVPKPEVIFKLEQ | 61 | P51508 | |
| ELLEALYPKLFKPEG | 161 | Q9NPC6 | |
| GYDLPVDAIPIKAAK | 2526 | P20929 |